The ACS Ethnicity Platelet Function Study

Trial Profile

The ACS Ethnicity Platelet Function Study

Phase of Trial: Phase IV

Latest Information Update: 13 Jun 2018

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 07 Jun 2018 Status changed from recruiting to completed.
    • 01 May 2013 Status changed from not yet recruiting to recruiting as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top